Literature DB >> 16484098

Cognitive development in schizophrenia: follow-back from the first episode.

Robert M Bilder1, Gail Reiter, Jay Bates, Todd Lencz, Philip Szeszko, Robert S Goldman, Delbert Robinson, Jeffrey A Lieberman, John M Kane.   

Abstract

Despite consensus that schizophrenia is a neurodevelopmental disorder characterized by cognitive deficits, objective data documenting the course of cognitive development remain sparse. We conducted a follow-back study of patients ascertained at the time of their initial episode of schizophrenia or schizoaffective disorder, and a group of demographically matched healthy volunteers. We obtained school records containing standardized achievement test scores from the 1st through 12th grades, and scholastic aptitude test results from the 11th and 12th grades, and examined the developmental trajectories of cognitive performance with respect to prospective examinations conducted following participants' enrollment in our study. We found significant differences in academic achievement tests as early as the first grade, with scores from participants who would later develop schizophrenia lagging behind their peers by 0.8 to 1.1 grade equivalents. This gap widened resulting in a difference between groups of 1.5 to 1.8 grade equivalents by the 12th grade. In the subset of patients for whom SAT scores were available, we found that WAIS-R Full Scale IQ was 11.5 points lower than predicted from earlier SAT scores, suggesting a substantial decline in cognitive ability accompanying the initial episode of illness. These findings suggest that schizophrenia is marked by substantial cognitive deficits in the first grade, that there may be additional subtle decline preceding the overt onset of psychotic symptoms, and that the initial episode of illness is marked by additional decline. These observations may help advance concepts of premorbid cognitive ability in the schizophrenia syndrome and constrain models of pathophysiology.

Entities:  

Mesh:

Year:  2006        PMID: 16484098     DOI: 10.1080/13803390500360554

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  39 in total

1.  The field of schizophrenia: strengths, weaknesses, opportunities, and threats.

Authors:  John M Kane; Barbara Cornblatt; Christoph U Correll; Terry Goldberg; Todd Lencz; Anil K Malhotra; Delbert Robinson; Philip Szeszko
Journal:  Schizophr Bull       Date:  2011-11-18       Impact factor: 9.306

2.  Longitudinal progression of frontal and temporal lobe changes in schizophrenia.

Authors:  Derin J Cobia; Matthew J Smith; Lei Wang; John G Csernansky
Journal:  Schizophr Res       Date:  2012-05-29       Impact factor: 4.939

3.  Brain Structure in Neuropsychologically Defined Subgroups of Schizophrenia and Psychotic Bipolar Disorder.

Authors:  Neil D Woodward; Stephan Heckers
Journal:  Schizophr Bull       Date:  2015-04-22       Impact factor: 9.306

4.  Cognitive deficits in schizophrenia: short-term and long-term.

Authors:  John M Kane; Todd Lencz
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

5.  Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis.

Authors:  Kristen A Woodberry; William R McFarlane; Anthony J Giuliano; Mary B Verdi; William L Cook; Stephen V Faraone; Larry J Seidman
Journal:  Schizophr Res       Date:  2013-02-22       Impact factor: 4.939

6.  MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.

Authors:  George C Nitzburg; Pamela Derosse; Katherine E Burdick; Bart D Peters; Chaya B Gopin; Anil K Malhotra
Journal:  Schizophr Res       Date:  2013-12-08       Impact factor: 4.939

Review 7.  Biomarkers in psychosis: an approach to early identification and individualized treatment.

Authors:  Heline Mirzakhanian; Fiza Singh; Kristin S Cadenhead
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

8.  Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.

Authors:  Max Lam; W David Hill; Joey W Trampush; Jin Yu; Emma Knowles; Gail Davies; Eli Stahl; Laura Huckins; David C Liewald; Srdjan Djurovic; Ingrid Melle; Kjetil Sundet; Andrea Christoforou; Ivar Reinvang; Pamela DeRosse; Astri J Lundervold; Vidar M Steen; Thomas Espeseth; Katri Räikkönen; Elisabeth Widen; Aarno Palotie; Johan G Eriksson; Ina Giegling; Bettina Konte; Annette M Hartmann; Panos Roussos; Stella Giakoumaki; Katherine E Burdick; Antony Payton; William Ollier; Ornit Chiba-Falek; Deborah K Attix; Anna C Need; Elizabeth T Cirulli; Aristotle N Voineskos; Nikos C Stefanis; Dimitrios Avramopoulos; Alex Hatzimanolis; Dan E Arking; Nikolaos Smyrnis; Robert M Bilder; Nelson A Freimer; Tyrone D Cannon; Edythe London; Russell A Poldrack; Fred W Sabb; Eliza Congdon; Emily Drabant Conley; Matthew A Scult; Dwight Dickinson; Richard E Straub; Gary Donohoe; Derek Morris; Aiden Corvin; Michael Gill; Ahmad R Hariri; Daniel R Weinberger; Neil Pendleton; Panos Bitsios; Dan Rujescu; Jari Lahti; Stephanie Le Hellard; Matthew C Keller; Ole A Andreassen; Ian J Deary; David C Glahn; Anil K Malhotra; Todd Lencz
Journal:  Am J Hum Genet       Date:  2019-08-01       Impact factor: 11.025

9.  DTNBP1 genotype influences cognitive decline in schizophrenia.

Authors:  Katherine E Burdick; Terry E Goldberg; Birgit Funke; John A Bates; Todd Lencz; Raju Kucherlapati; Anil K Malhotra
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

Review 10.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.